Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
The Gabelli Healthcare & Wellness Trust
Bear Case (25th pct.)
-75.0% vs price
Base Case (Median)
-68.6% vs price
Bull Case (75th pct.)
-53.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $3.05 | -68.6% | High (40%) |
| PE Comparable | $1.80 | -81.4% | Medium (25%) |
| Graham Number | $5.91 | -39.2% | High (80%) |
Based on 3 out of 8 methods, GRX appears overvalued at the current price of $9.72. The base case fair value of $3.05 implies 68.6% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.